Home » Topics » Regulatory » Patents

Patents
RSS

Sunshine Lake Pharma describes new SLC22A12 and xanthine oxidase inhibitors

Oct. 1, 2018

Korea Research Institute of Chemical Technology and collaborators patent GPR119 agonists

Oct. 1, 2018

VPS-3 presents HDAC6 inhibitors

Sep. 28, 2018

U.S. researchers divulge bacterial efflux pump inhibitors

Sep. 28, 2018

Theravance Biopharma presents new JAK inhibitors

Sep. 28, 2018

Progenra identifies new USP7 inhibitors for cancer

Sep. 28, 2018

Sunshine Lake Pharma patents influenza H1N1 inhibitors

Sep. 28, 2018

Lycera patents RORC agonists as IL-17 production enhancers

Sep. 27, 2018

Lupin identifies SCN9A blockers

Sep. 27, 2018

3M Pharmaceuticals synthesizes new cytokine biosynthesis inducers

Sep. 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...